Denteric Receives FDA IND Approval for Innovative Vaccine Targeting Periodontitis Inflammation Denteric has announced FDA clearance for GPV381, an innovative vaccine aimed at treating inflammation caused by periodontitis. This breakthrough could transform oral health care.

Denteric Receives FDA IND Approval for Innovative Vaccine Targeting Periodontitis Inflammation #United_States #Melbourne #periodontitis #Denteric #GPV381